German Exchange Growth Stocks With Significant Insider Ownership
Reviewed by Simply Wall St
Amidst a backdrop of easing monetary policy in Europe, Germany's DAX has shown positive momentum, reflecting investor optimism following the European Central Bank's recent rate cuts. In this environment, growth companies with substantial insider ownership present an intriguing proposition as they often signal confidence from those closest to the business.
Top 10 Growth Companies With High Insider Ownership In Germany
Name | Insider Ownership | Earnings Growth |
Stemmer Imaging (XTRA:S9I) | 27.8% | 23.2% |
Multitude (XTRA:E4I) | 31% | 20.7% |
Exasol (XTRA:EXL) | 25.3% | 117.1% |
Deutsche Beteiligungs (XTRA:DBAN) | 39.6% | 54.1% |
pferdewetten.de (XTRA:EMH) | 20.6% | 97.9% |
adidas (XTRA:ADS) | 16.6% | 40.4% |
Alelion Energy Systems (DB:2FZ) | 37.4% | 106.6% |
Beyond Frames Entertainment (DB:8WP) | 10.8% | 112.2% |
Friedrich Vorwerk Group (XTRA:VH2) | 18.8% | 25.5% |
elumeo (XTRA:ELB) | 25.8% | 129.5% |
Let's review some notable picks from our screened stocks.
Hypoport (XTRA:HYQ)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Hypoport SE develops and markets technology platforms for the financial services, property, and insurance industries in Germany, with a market cap of €1.92 billion.
Operations: The company's revenue is primarily derived from its Credit Platform (€157.97 million) and Insurance Platform (€66.89 million).
Insider Ownership: 33.5%
Hypoport SE, a German company with significant insider ownership, recently joined the MDAX Index, marking its growth trajectory. The company became profitable this year with earnings expected to grow significantly at 34% annually over the next three years. Revenue is also projected to rise by 12.5% per annum, outpacing the German market average. Despite high share price volatility and low forecasted return on equity (9.7%), Hypoport's financials show promising expansion potential.
- Click to explore a detailed breakdown of our findings in Hypoport's earnings growth report.
- Our valuation report here indicates Hypoport may be overvalued.
Verve Group (XTRA:M8G)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Verve Group SE operates a software platform facilitating the automated buying and selling of digital advertising space in North America and Europe, with a market cap of €651.32 million.
Operations: The company's revenue is primarily derived from its Supply Side Platforms (SSP) at €341.35 million and Demand Side Platforms (DSP) at €57.59 million.
Insider Ownership: 25.1%
Verve Group SE demonstrates strong growth potential, with earnings forecasted to grow significantly at 20.1% annually, surpassing the German market average. The company reported substantial revenue and net income increases in its recent earnings report, indicating robust performance. Despite a highly volatile share price and past shareholder dilution, Verve Group is trading at a significant discount compared to its estimated fair value. Recent inclusion in the S&P Global BMI Index underscores its expanding market presence.
- Unlock comprehensive insights into our analysis of Verve Group stock in this growth report.
- In light of our recent valuation report, it seems possible that Verve Group is trading behind its estimated value.
Redcare Pharmacy (XTRA:RDC)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Redcare Pharmacy NV is an online pharmacy operating in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of €2.94 billion.
Operations: The company generates revenue from two primary segments: €1.74 billion from the DACH region and €391 million from its international operations.
Insider Ownership: 17.2%
Redcare Pharmacy is positioned for growth, with revenue forecasted to increase by 17.5% annually, outpacing the German market average. Recent sales guidance was raised to between €2.35 billion and €2.5 billion for 2024, highlighting positive momentum despite a net loss of €12.07 million in the first half of the year. While insiders have not significantly bought shares recently, the stock trades at a notable discount to its estimated fair value, suggesting potential upside as profitability improves over three years.
- Click here to discover the nuances of Redcare Pharmacy with our detailed analytical future growth report.
- Our comprehensive valuation report raises the possibility that Redcare Pharmacy is priced higher than what may be justified by its financials.
Seize The Opportunity
- Discover the full array of 22 Fast Growing German Companies With High Insider Ownership right here.
- Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
- Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.
Want To Explore Some Alternatives?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About XTRA:M8G
Verve Group
Operates a software platform for the automated buying and selling of digital advertising space in North America and Europe.
Undervalued with reasonable growth potential.